Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 29
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Guide de la pratique transfusionnelle | View Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Prokopchuk-Gauk O, Solh Z | 2017 | Guide de la pratique transfusionnelle | View Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Health care providers | Benchmarking and standard setting |
Réduction des agents pathogènes dans les produits de fractionnement | Bigham M | 2019 | Guide de la pratique transfusionnelle | View Réduction des agents pathogènes dans les produits de fractionnement | Health care providers | Benchmarking and standard setting |
Épreuves prétransfusionnelles | Lane D | 2017 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |
Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Zeller M, Petraszko T | 2018 | Guide de la pratique transfusionnelle | View Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Health care providers | Other |
Épreuves prétransfusionnelles | Duncan J | 2020 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Chapitre 2: Les composants sanguins | Gupta A, Bigham M | 2021 | Guide de la pratique transfusionnelle | View Chapitre 2: Les composants sanguins | Health care providers | Benchmarking and standard setting |
Chaptire 16: Don autologue préopératoire | Foster T, Yan M | 2021 | Guide de la pratique transfusionnelle | View Chaptire 16: Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
Chapter 17. Troubles de l’hémostase et angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapter 17. Troubles de l’hémostase et angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Chapitre 10. Les réactions transfusionnelles | Laureano M, Khandelwal A, Yan M | 2022 | Guide de la pratique transfusionnelle | View Chapitre 10. Les réactions transfusionnelles | Health care providers | Benchmarking and standard setting |
Cord blood clinical processing, cryopreservation, and storage | Elmoazzen H, Holovati JL | 2015 | Methods in Molecular Biology | View Cord blood clinical processing, cryopreservation, and storage | Other | Other |
Costs and benefits of non-invasive fetal RhD determination | Teitelbaum L, Metcalfe A, Clarke G, Parboosingh JS, Wilson RD, Johnson JM | 2015 | Ultrasound Obstet Gynecol | View Costs and benefits of non-invasive fetal RhD determination | Health care providers | New or improved product or process |
Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries | Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H | 2012 | Adv Hematol | View Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries | Researchers | Basic research |
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes | Bernardo L, Denomme GA, Shah K, Lazarus AH | 2014 | Adv Hematol | View RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes | Researchers | Basic research |
Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression | Hubert A, Subra C, Jenabian MA, Tremblay Labrecque PF, Tremblay C, Laffont B, Provost P, Routy JP, Gilbert C | 2015 | J Acquir Immune Defic Syndr | View Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression | Researchers | Basic research |
c-Src and Pyk2 protein tyrosine kinases play protective roles in early HIV-1 infection of CD4+ T cell lines | McCarthy SDS, Jung D, Sakac D, Branch DR | 2014 | J Acquir Immune Defic Syndr | View c-Src and Pyk2 protein tyrosine kinases play protective roles in early HIV-1 infection of CD4+ T cell lines | Researchers | Basic research |
Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T?Cells or in Humanized NSG Mice | McCarthy SDS, Leontyev D, Nicoletti P, Binnington B, Kozlowski HN, Ostrowski M, Cochrane A, Branch DR, Wong RW | 2019 | J Acquir Immune Defic Syndr | View Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T?Cells or in Humanized NSG Mice | Researchers | Basic research |
Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts | Kaushal R, Jahan S, McGregor C, Pineault N | 2022 | Cytotherapy | View Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts | Researchers | New or improved product or process |
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? | Kirkham AM, Bailey AJM, Shorr R, Lalu MM, Fergusson DA, Allan DS | 2023 | Cytotherapy | View Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? | Researchers | Clinical research |
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP | 2021 | Cytotherapy | View The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Blood operators | New or improved product or process |
Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Simard C, Fournier D, Pineault N, Trépanier P | 2022 | Cytotherapy | View Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Researchers | New or improved product or process |
Multi-laboratory assay for harmonization of enumeration of viable CD34+ and CD45+ cells in frozen cord blood units | Fournier D, Lewin A, Simard C, Trépanier P, Néron S, Ballerini L, Codinach M, Elmoazzen H, Halpenny M, Kogler G, Liedtke S, Louis I, Molluna CA, Pineault N, Prasath A, Querol S, Saccardi R, Sutherland DR, Thérien C, Urbani S | 2020 | Cytotherapy | View Multi-laboratory assay for harmonization of enumeration of viable CD34+ and CD45+ cells in frozen cord blood units | Researchers | Benchmarking and standard setting |
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Maganti HB, Kirkham AM, Bailey AJM, Shorr R, Kekre N, Pineault N, Allan DS | 2022 | Cytotherapy | View Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Researchers | Clinical research |
CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1 | Marquez-Curtis LA, Gul-Uludag H, Xu P, Chen J, Janowska-Wieczorek A | 2013 | Cytotherapy | View CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1 | Researchers | Basic research |
Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q | Qiu Y, Marquez-Curtis LA, Janowska-Wieczorek A | 2012 | Cytotherapy | View Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q | Researchers | Basic research |
Transient warming affects potency of cryopreserved cord blood units | Pasha R, Howell A, Turner TR, Halpenny M, Elmoazzen H, Acker JP, Pineault N | 2020 | Cytotherapy | View Transient warming affects potency of cryopreserved cord blood units | Researchers | New or improved product or process |
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Shah A, Solms A, Wiegmann S, Ahsman M, Berntorp E, Tiede A, Iorio A, Mancuso ME, Zhivkov T, Lissitchkov T | 2019 | Ann Hematol | View Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Health care providers | Clinical research |
Mechanisms of platelet recovery in ITP associated with therapy | Pang SJY, Lazarus AH | 2010 | Ann Hematol | View Mechanisms of platelet recovery in ITP associated with therapy | Researchers | Basic research |
The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments | Hillis CM, Schimmer AD, Couban S, Crowther MA | 2015 | Ann Hematol | View The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments | Health care providers | Benchmarking and standard setting |
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Solms A, Shah A, Berntorp E, Tiede A, Iorio A, Linardi C, Ahsman M, Mancuso ME, Zhivkov T, Lissitchkov T | 2020 | Ann Hematol | View Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Researchers | Clinical research |
Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia | Xu SQ, Wang CY, Zhu XJ, Dong XY, Shi Y, Peng J, Qin P, Sun JZ, Guo C, Ni H, Hou M | 2012 | Ann Hematol | View Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia | Researchers | Basic research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Defining Significant Events for Neonatal and Pediatric Transport: Results of a Combined Delphi and Consensus Meeting Process | Gunz A, McNally J, Whyte H, O'Hearn K, Foster J, Parker M, Dhanani S | 2016 | J Pediatr Intensive Care | View Defining Significant Events for Neonatal and Pediatric Transport: Results of a Combined Delphi and Consensus Meeting Process | Researchers | Clinical research |
Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo | Imran ul-haq M, Hamilton JL, Lai BF, Shenoi RA, Horte S, Constantinescu I, Leitch HA, Kizhakkedathu JN | 2013 | ACS Nano | View Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo | Researchers | Basic research |
Design, implementation, and evaluation of a knowledge translation intervention to increase organ donation after cardiocirculatory death in Canada: a study protocol | Squires JE, Grimshaw JM, Taljaard M, Linklater S, Chasse M, Shemie SD, Knoll GA | 2014 | Implement Sci | View Design, implementation, and evaluation of a knowledge translation intervention to increase organ donation after cardiocirculatory death in Canada: a study protocol | Researchers | Other |
Designing ice recrystallization inhibitors: from antifreeze (glyco)proteins to small molecules | Balcerzak AK, Capicciotti CJ, Briard JG, Ben RN | 2014 | RSC Adv | View Designing ice recrystallization inhibitors: from antifreeze (glyco)proteins to small molecules | Researchers | Basic research |
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Trant JF, Briggs RA, Capicciotti C, Ben RN | 2013 | RSC Adv | View Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Researchers | Basic research |
Detection of bacterial adherence and biofilm formation on medical surfaces | Loza-Correa M, Ramirez-Arcos S | 2016 | Biofilms and implantable medical devices: infection and control | View Detection of bacterial adherence and biofilm formation on medical surfaces | Researchers | New or improved product or process |
Determination of the biological form of human cytomegalovirus DNA in the plasma of solid-organ transplant recipients | Tong Y, Pang XL, Mabilangan C, Preiksaitis JK | 2017 | J Infect Dis | View Determination of the biological form of human cytomegalovirus DNA in the plasma of solid-organ transplant recipients | Researchers | Clinical research |
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Asamoah-Boaheng M, Goldfarb DM, Karim ME, O’Brien SF, Wall N, Drews SJ, Barakauskas V, Jassem AN, Grunau B | 2022 | J Infect Dis | View The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Researchers | Clinical research |
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M | 2014 | Platelets | View Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Health care providers | Clinical research |
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Hwang SR, Wang Y, Weil EL, Padmanabhan A, Warkentin TE, Pruthi RK | 2020 | Platelets | View Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Health care providers | Clinical research |
Development of a high-yield expression and purification system for platelet factor 4 | Huynh A, Arnold DM, Moore JC, Smith JW, Kelton JG, Nazy I | 2017 | Platelets | View Development of a high-yield expression and purification system for platelet factor 4 | Researchers | Basic research |
Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia | Gabe C, Liu Y, Duncan J, St John M, Lucier KJ, Kimmel D, Kelton JG, Arnold DM | 2023 | Platelets | View Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia | Researchers | Clinical research |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia | Kapur R, Aslam R, Kim M, Guo L, Ni H, Segel GB, Semple JW | 2016 | Platelets | View Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia | Researchers | Basic research |